Zobrazeno 1 - 10 of 76 pro vyhledávání: '"J.-H. Cheon"'
1
P518 Safety of upadacitinib in ulcerative colitis: Long-term data from the phase 3 open-label extension study (U-ACTIVATE)
Autor: R Panaccione, G Lichtenstein, H Nakase, A Armuzzi, T Kucharzik, G Levy, H Palac, M Kujawski, J Klaff, J H Cheon
Publikováno v: Journal of Crohn's and Colitis. 17:i644-i646
Background Upadacitinib (UPA), an oral reversible and selective JAK inhibitor, has demonstrated efficacy, with a well-characterised safety profile, in two replicate induction studies of UPA 45 mg once daily (QD; U-ACHIEVE induction and U-ACCOMPLISH),
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::681676acee19126d17f3566ee14c440b
https://doi.org/10.1093/ecco-jcc/jjac190.0648
Zobrazit plný text záznamu
2
P031 CKD-506, a new histone deacetylase 6 inhibitor, suppresses immune cells and restores intestinal epithelial function
Autor: J Y Lee, H W Ma, J H Kim, I S Park, M Son, K H Ryu, J Shin, W H Kim, S W Kim, J H Cheon
Publikováno v: Journal of Crohn's and Colitis. 17:i198-i199
Background Inflammatory bowel disease (IBD) represents a group of chronic immune-mediated diseases of the gastrointestinal tract, characterized by recurrent inflammation and consequential damage of the gastrointestinal tract. Histone deacetylases (HD
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::1f9344e49c86aad054e80efce1205d90
https://doi.org/10.1093/ecco-jcc/jjac190.0161
Zobrazit plný text záznamu
3
P358 Long-term clinical outcomes of intestinal Behçet’s disease: a 30-year cohort study at a tertiary hospital in South Korea
Autor: J Park, S J Park, J J Park, T I Kim, W H Kim, J H Cheon
Publikováno v: Journal of Crohn's and Colitis. 17:i493-i493
Background Long-term clinical data on intestinal Behçet’s disease (BD) are scarce because of the rarity of this disease, and many issues remain unresolved due to the difficulty in performing a well-designed clinical trial or epidemiologic study. W
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::6235ace7c3410bdd3fa3e2dbc3595a10
https://doi.org/10.1093/ecco-jcc/jjac190.0488
Zobrazit plný text záznamu
4
P200 Hepatic Steatosis but not Fibrosis is independently associated with poor outcomes in patients with Inflammatory Bowel Disease
Autor: H K Hyun, H W Lee, P Jihye, S J Park, J J Park, T I Kim, W H Kim, J S Lee, B K Kim, J Y Park, D Y Kim, S H Ahn, S U Kim, J H Cheon
Publikováno v: Journal of Crohn's and Colitis. 17:i352-i352
Background Increased prevalence of nonalcoholic fatty liver disease (NAFLD) and inflammatory bowel disease (IBD) has been reported; however, the effects of NAFLD on the outcome of IBD remains unclear. We investigated whether the presence of NAFLD cou
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::e716d0e4b211d10409a347fcaad45bab
https://doi.org/10.1093/ecco-jcc/jjac190.0330
Zobrazit plný text záznamu
5
P223 Neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in patient with intestinal Behçet’s disease as a marker of disease activity and prognosis
Autor: B W Jung, E A Kang, S J Park, J J Park, J H Cheon, T I Kim, J Park
Publikováno v: Journal of Crohn's and Colitis. 16:i273-i274
Background The neutrophil to lymphocyte ratio (NLR) and platelet to lymphocyte ratio (PLR) are used as a diagnostic marker, disease activity marker, and prognostic marker in patients with Crohn’s disease and ulcerative colitis. We aimed to investig
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::8c58c108a6b9834cb98312712a698864
https://doi.org/10.1093/ecco-jcc/jjab232.350
Zobrazit plný text záznamu
6
P312 Combination corticosteroids with, 5-aminosalicylic acid versus corticosteroids alone in the treatment of hospitalized patients with acute severe ulcerative colitis: A multi-center randomized controlled trial
Autor: S Ben-Horin, O Har-Noy, K H Katsanos, R Xavier, M H Chen, X Gao, D Schwartz, J H Cheon, M Cesarini, D Bojic, M Protic, A Theodoropoulou, H Abu-Kaf, T Engel, J Tang, P Veyrard, X Lin, R Mao, D Christodoulou, K Karmiris, T Knezevic-Ivanovski
Publikováno v: Journal of Crohn's and Colitis. 16:i337-i337
Background Corticosteroids are the mainstay of treatment for hospitalized patients with acute severe ulcerative colitis (ASUC). However, whether the addition/continuation of, 5-aminosalicylates (5ASA) with corticosteroids during hospitalization is su
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::202aacf2a2d7dae7ab7d95fedee37fc3
https://doi.org/10.1093/ecco-jcc/jjab232.439
Zobrazit plný text záznamu
7
P602 Changes in emotional health and work-related outcomes in patients with moderate to severe ulcerative colitis 1 year after diagnosis: Results from the MOSAIK cohort in Korea
Autor: Y PARK, J H Cheon, Y S Park, K C Huh, J E Shin, J M Cha, Y S Kim, C S Eun, S M Yoon, B D Ye, B Seo, Y Kim
Publikováno v: Journal of Crohn's and Colitis. 14:S502-S503
Background As the treatment paradigm of inflammatory bowel disease changes towards patient-centred treatment, it is becoming increasingly important to measure patient-reported outcomes (PROs). We aimed to identify the changes of emotional health and
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::c3ac984c7c08d97735aeb3defeaac247
https://doi.org/10.1093/ecco-jcc/jjz203.730
Zobrazit plný text záznamu
8
P001 The novel DYRK1a inhibitor VRN024219 alleviates disease severity on the IBD mouse models by modulating T-cell differentiation
Autor: D H Seo, H W Ma, S Kim, D H Kim, H K Kim, S H Lee, J Y Ahn, S H Yoon, D K Kim, J H Cheon
Publikováno v: Journal of Crohn's and Colitis. 14:S129-S129
Background DYRK1A belongs to dual-specificity tyrosine (Y) phosphorylation regulated kinase (DYRK) family which is known to be activated through autophosphorylation of tyrosine residues in the activation loop and phosphorylates their substrates on se
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::8fc2b5fbce9794321e536e8df0b6bfdb
https://doi.org/10.1093/ecco-jcc/jjz203.130
Zobrazit plný text záznamu
9
Profile Loss Prediction for High Pressure Steam Turbines
Autor: J. H. Cheon, A. Pacák, C. R. Kang, M. Šťastný, P. Milčák
Publikováno v: Volume 8: Microturbines, Turbochargers and Small Turbomachines; Steam Turbines.
A method is presented for predicting the energy loss for a 2D turbine cascade blade operating in subsonic regions where the exit Mach number ≤ 0.8. A prediction method based on entropy creation was used to analyze the cascade profile loss mechanism
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::dbd6633ff91c3e1a48554f37aba7b076
https://doi.org/10.1115/gt2016-56114
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje